scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1161/ATVBAHA.108.165530 |
P8608 | Fatcat ID | release_7pzzwoxnrjan7m7vw4idcxovze |
P932 | PMC publication ID | 2733228 |
P698 | PubMed publication ID | 19359659 |
P50 | author | Peter Libby | Q22670611 |
Ralph Weissleder | Q7288259 | ||
P2093 | author name string | Farouc A Jaffer | |
P2860 | cites work | Characterization and performance of a near-infrared 2-deoxyglucose optical imaging agent for mouse cancer models | Q24657493 |
In vivo imaging of tumors with protease-activated near-infrared fluorescent probes | Q28141852 | ||
Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles | Q30987755 | ||
Impact of field strength and iron oxide nanoparticle concentration on the linearity and diagnostic accuracy of off-resonance imaging | Q31132362 | ||
Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo | Q46881126 | ||
A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. | Q48114221 | ||
Gradient echo acquisition for superparamagnetic particles with positive contrast (GRASP): sequence characterization in membrane and glass superparamagnetic iron oxide phantoms at 1.5T and 3T. | Q51306514 | ||
Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI. | Q51935001 | ||
Molecular imaging of cardiovascular disease. | Q53466788 | ||
Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. | Q53541975 | ||
Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. | Q55032942 | ||
Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis | Q56894441 | ||
Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle | Q57187719 | ||
Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging | Q57188260 | ||
In vivo imaging of proteolytic activity in atherosclerosis | Q57188411 | ||
Molecular Imaging of Atherosclerotic Plaques Using a Human Antibody Against the Extra-Domain B of Fibronectin | Q57912122 | ||
Optical Visualization of Cathepsin K Activity in Atherosclerosis With a Novel, Protease-Activatable Fluorescence Sensor | Q58816186 | ||
Angiographic evolution of coronary artery morphology in unstable angina | Q70018285 | ||
Fluorescence molecular tomography resolves protease activity in vivo | Q74391149 | ||
Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo | Q79792625 | ||
Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis | Q79851922 | ||
Correlation of carotid atheromatous plaque inflammation using USPIO-enhanced MR imaging with degree of luminal stenosis | Q81200106 | ||
Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle | Q31141702 | ||
Noninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits using "positive contrast" magnetic resonance imaging | Q31167048 | ||
Detection of macrophage activity in atherosclerosis in vivo using multichannel, high-resolution laser scanning fluorescence microscopy. | Q33242239 | ||
Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice | Q33243608 | ||
Intravascular detection of inflamed atherosclerotic plaques using a fluorescent photosensitizer targeted to the scavenger receptor. | Q33619336 | ||
In vivo molecular target assessment of matrix metalloproteinase inhibition | Q33949202 | ||
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer | Q34207093 | ||
Simultaneous PET-MRI: a new approach for functional and morphological imaging | Q34765886 | ||
Shedding light onto live molecular targets | Q35039563 | ||
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. | Q35552554 | ||
Looking and listening to light: the evolution of whole-body photonic imaging | Q36070062 | ||
Molecular optical imaging: applications leading to the development of present day therapeutics | Q36129726 | ||
Atherosclerosis and proteinase activation | Q36352662 | ||
The immune response in atherosclerosis: a double-edged sword | Q36508676 | ||
Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization | Q36915918 | ||
Three-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model | Q37039058 | ||
Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis | Q37085672 | ||
Imaging of atherosclerotic cardiovascular disease | Q37089743 | ||
Multifunctional magnetic nanoparticles for targeted imaging and therapy | Q37174947 | ||
Advances in fluorescence imaging of the cardiovascular system. | Q37177639 | ||
Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis | Q37311936 | ||
Nanotechnology in medical imaging: probe design and applications. | Q37341362 | ||
Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate | Q37484967 | ||
Imaging inflammation of the pancreatic islets in type 1 diabetes | Q37494120 | ||
A new atherosclerotic lesion probe based on hydrophobically modified chitosan nanoparticles functionalized by the atherosclerotic plaque targeted peptides | Q38501188 | ||
Fluorescence reflectance imaging of macrophage-rich atherosclerotic plaques using an alphavbeta3 integrin-targeted fluorochrome | Q39928440 | ||
Synthesis and evaluation of a novel fluorescent photoprobe for imaging matrix metalloproteinases | Q39994028 | ||
In vivo imaging of siRNA delivery and silencing in tumors | Q40166593 | ||
A macrophage-targeted theranostic nanoparticle for biomedical applications. | Q40189479 | ||
Cellular imaging of inflammation in atherosclerosis using magnetofluorescent nanomaterials | Q40291013 | ||
A fluorescent probe for the detection of myeloperoxidase activity in atherosclerosis-associated macrophages | Q42679591 | ||
Preclinical evaluation and phase I clinical trial of a 99mTc-labeled synthetic polymer used in blood pool imaging | Q42680049 | ||
Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. | Q43153036 | ||
Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles | Q44616397 | ||
In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. | Q44913030 | ||
Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. | Q46006433 | ||
Monitoring therapeutical intervention with ezetimibe using targeted near-infrared fluorescence imaging in experimental atherosclerosis | Q46427391 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | atherosclerosis | Q12252367 |
P304 | page(s) | 1017-1024 | |
P577 | publication date | 2009-04-09 | |
P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
P1476 | title | Optical and multimodality molecular imaging: insights into atherosclerosis | |
P478 | volume | 29 |
Q55339713 | A Dual-Modality Hybrid Imaging System Harnesses Radioluminescence and Sound to Reveal Molecular Pathology of Atherosclerotic Plaques. |
Q39744489 | A novel molecule integrating therapeutic and diagnostic activities reveals multiple aspects of stem cell-based therapy. |
Q33590975 | Assessment of global cardiac uptake of radiolabeled iron oxide nanoparticles in apolipoprotein-E-deficient mice: implications for imaging cardiovascular inflammation |
Q35690558 | Biochemical characterization of atherosclerotic plaques by endogenous multispectral fluorescence lifetime imaging microscopy |
Q37228234 | Biological imaging of atherosclerosis: moving beyond anatomy |
Q37762507 | Biomarkers of vulnerable atheromatous plaques: translational medicine perspectives. |
Q49788067 | Biomimetic nanoparticles with enhanced affinity towards activated endothelium as versatile tools for theranostic drug delivery |
Q37053665 | Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation. |
Q33693074 | Cardiovascular molecular imaging |
Q45064544 | Cellular Uptake of Plain and SPION-Modified Microbubbles for Potential Use in Molecular Imaging |
Q28538538 | Comprehensive evaluation of the anti-angiogenic and anti-neoplastic effects of Endostar on liver cancer through optical molecular imaging |
Q57810163 | Computational Cardiology |
Q41459121 | Convenient and effective ICGylation of magnetic nanoparticles for biomedical applications. |
Q38848673 | Detection and treatment of atherosclerosis using nanoparticles |
Q36396054 | Detection of atherosclerotic lesions and intimal macrophages using CD36-targeted nanovesicles |
Q30525312 | Detection of hydroxyapatite in calcified cardiovascular tissues |
Q42736765 | Detection of macrophages via paramagnetic vesicles incorporating oxidatively tailored cholesterol ester: an approach for atherosclerosis imaging. |
Q50516003 | Development and haematotoxicological evaluation of doped hydroxyapatite based multimodal nanocontrast agent for near-infrared, magnetic resonance and X-ray contrast imaging. |
Q36095999 | Discrete bimodal probes for thrombus imaging |
Q41573147 | Drug Discovery by Molecular Imaging and Monitoring Therapy Response in Lymphoma. |
Q46232358 | Efficient synthesis of fluorescent-PET probes based on [¹⁸F]BODIPY dye. |
Q30475719 | Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases |
Q35086168 | FRET-based and other fluorescent proteinase probes. |
Q35262149 | Fiber-optic system for dual-modality imaging of glucose probes 18F-FDG and 6-NBDG in atherosclerotic plaques |
Q37425779 | Fluorescent Bisphosphonate and Carboxyphosphonate Probes: A Versatile Imaging Toolkit for Applications in Bone Biology and Biomedicine |
Q36731084 | Formulation, characteristics and antiatherogenic bioactivities of CD36-targeted epigallocatechin gallate (EGCG)-loaded nanoparticles |
Q42690584 | Glycolaldehyde and maleyl conjugated human serum albumin as potential macrophage-targeting carriers for molecular imaging purposes |
Q36572425 | High-resolution molecular imaging via intravital microscopy: illuminating vascular biology in vivo |
Q39763138 | Hybrid FMT-MRI applied to in vivo atherosclerosis imaging |
Q57907277 | Imaging and quantifying the morphology of an organic–inorganic nanoparticle at the sub-nanometre level |
Q38844535 | Imaging of coronary atherosclerosis - evolution towards new treatment strategies |
Q30448146 | Improving quantification of intravascular fluorescence imaging using structural information |
Q34288844 | In vivo fluorescence reflectance imaging of protease activity in a mouse model of post-traumatic osteoarthritis |
Q37791278 | In vivo imaging in cancer |
Q33994368 | In vivo near infrared fluorescence (NIRF) intravascular molecular imaging of inflammatory plaque, a multimodal approach to imaging of atherosclerosis |
Q30472773 | Indocyanine green enables near-infrared fluorescence imaging of lipid-rich, inflamed atherosclerotic plaques |
Q42134447 | Inflammation modulates murine venous thrombosis resolution in vivo: assessment by multimodal fluorescence molecular imaging |
Q34230328 | Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo |
Q64986208 | Intravascular NIRF Molecular Imaging Approaches in Coronary Artery Disease. |
Q39874491 | Intravascular near-infrared fluorescence molecular imaging of atherosclerosis |
Q27334277 | Intravascular optical imaging of high-risk plaques in vivo by targeting macrophage mannose receptors |
Q26852822 | Intravascular optical imaging technology for investigating the coronary artery |
Q36761866 | Long-term prevalence of NIRF-labeled magnetic nanoparticles for the diagnostic and intraoperative imaging of inflammation. |
Q36088710 | MRI as a Novel In Vivo Approach for Assessing Structural Changes of Chlamydia Pathology in a Mouse Model. |
Q38820074 | Macrophages in Vascular Inflammation: Origins and Functions |
Q30475508 | Mass spectrometric imaging for biomedical tissue analysis |
Q92378330 | Molecular Imaging of the Heart |
Q30474772 | Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification |
Q41819473 | Molecular imaging of atherosclerosis: clinical state-of-the-art |
Q36036217 | Molecular imaging of fibrin deposition in deep vein thrombosis using fibrin-targeted near-infrared fluorescence |
Q58816167 | Molecular imaging of macrophage protease activity in cardiovascular inflammation in vivo |
Q30467394 | Multispectral optoacoustic tomography of matrix metalloproteinase activity in vulnerable human carotid plaques |
Q38828033 | Nanomedicine Meets microRNA: Current Advances in RNA-Based Nanotherapies for Atherosclerosis |
Q37724631 | Nanomedicine and Cardiovascular Disease |
Q33902889 | Near-infrared autofluorescence induced by intraplaque hemorrhage and heme degradation as marker for high-risk atherosclerotic plaques. |
Q39068959 | Near-infrared fluorescence imaging of murine atherosclerosis using an oxidized low density lipoprotein-targeted fluorochrome |
Q87816699 | Non-destructive two-photon excited fluorescence imaging identifies early nodules in calcific aortic-valve disease |
Q37663867 | Optical molecular imaging in atherosclerosis |
Q37859341 | Optical molecular imaging of atherosclerosis using nanoparticles: shedding new light on the darkness |
Q37772807 | Optical techniques for the molecular imaging of angiogenesis |
Q37058474 | Optical tecnology developments in biomedicine: history, current and future |
Q34736942 | Paramagnetic liposomes for molecular MRI and MRI-guided drug delivery. |
Q30455490 | Perspectives and opportunities for nanomedicine in the management of atherosclerosis. |
Q34537454 | Pioglitazone suppresses inflammation in vivo in murine carotid atherosclerosis: novel detection by dual-target fluorescence molecular imaging. |
Q36792762 | Positron Emission Tomography and Magnetic Resonance Imaging of Cellular Inflammation in Patients with Abdominal Aortic Aneurysms |
Q36339573 | Quantitative In Vivo Detection of Chlamydia muridarum Associated Inflammation in a Mouse Model Using Optical Imaging |
Q36355372 | Quantitative Longitudinal Imaging of Vascular Inflammation and Treatment by Ezetimibe in apoE Mice by FMT Using New Optical Imaging Biomarkers of Cathepsin Activity and α(v)β(3) Integrin |
Q35058188 | Report of the National Heart, Lung, and Blood Institute working group on the translation of cardiovascular molecular imaging |
Q35433466 | Selective inhibition of matrix metalloproteinase-13 increases collagen content of established mouse atherosclerosis |
Q90022992 | Small-animal 360-deg fluorescence diffuse optical tomography using structural prior information from ultrasound imaging |
Q26776370 | Smart nanosystems: Bio-inspired technologies that interact with the host environment |
Q51446926 | Strong correlation between early stage atherosclerosis and electromechanical coupling of aorta. |
Q39782073 | The catheterization laboratory and interventional vascular suite of the future: anticipating innovations in design and function |
Q38962280 | Tumor vascular homing endgolin-targeted radioimmunotherapy in hepatocellular carcinoma |
Q38989758 | Ultrasound guided fluorescence molecular tomography with improved quantification by an attenuation compensated Born-normalization and in vivo preclinical study of cancer |
Q37729836 | Will molecular optical imaging have clinically important roles in stroke management, and how? |
Search more.